NCT06940388
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06940388
Title Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer. (TOTAL)
Acronym TOTAL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors brenner baruch
Indications
Therapies
Age Groups: adult | senior
Covered Countries ISR | DEU

Facility Status City State Zip Country Details
Johannes Gutenberg-University Clinic, Mainz, Germany 1.Dept. Medicine, Prof. Peter R. Galle NOT_YET_RECRUITING Mainz Germany Details
Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital RECRUITING Petah Tikva Israel Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field